Gadofosveset Injectable Solution 0.03 mmol/kg Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 0.03 mmol/kg

Reference Brands: Ablivar(US & EU)

Category: Contrast Agent

Gadofosveset is a gadolinium-based contrast agent that binds to serum albumin, prolonging blood vessel retention and enhancing vascular imaging. It provides high-resolution angiography, improved visualization of blood vessels, and supports accurate diagnosis of cardiovascular and vascular diseases. Benefits include detailed imaging, longer study duration, and early disease detection.

Product Description: Gadofosveset, marketed as Ablivar, is approved in the US by the FDA and in the EU via EMA for high-resolution vascular MRI imaging. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing requirements. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and global availability, enabling precise cardiovascular and vascular imaging worldwide, supporting early diagnosis and treatment planning to improve patient outcomes.